Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abstract, Academy, adagrasib, AEs, aforementioned, al, anemia, Apr, arm, atezolizumab, Australia, begun, bevacizumab, Biden, biliary, Bio, Biogen, Biology, bioresearch, biweekly, BNP, BTC, Cadillac, CBR, CDMO, cholangiocarcinoma, classification, combat, compliant, concomitant, conduit, constantly, constitutionality, correctly, cultural, dataset, dealing, deliverance, DGPR, dismissed, dissemination, diversified, DOR, driven, durable, earnout, EC, elevated, Elpiscience, endothelial, excessive, excise, explore, female, FGFR, fourth, freely, front, Fuji, gastrointestinal, GMP, gouging, Goyal, Handok, harbor, harboring, hypertension, implicit, Importantly, Indian, infigratinib, inflation, instated, instructed, ipilimumab, irinotecan, IRS, issuable, Japan, Kalled, Korea, Korean, lab, laid, largest, leasehold, Leerink, linear, locked, main, male, microvasculature, Miranda, Modernization, Molecular, month, moratorium, MTD, NaN, Nasdaq, neutropenia, nivolumab, notified, onward, Ophthalmology, ovarian, paclitaxel, pancreatic, Parliament, path, pemigatinib, plenary, plot, PR, preapproval, pretreated, prominent, prostate, PRs, pulmonary, reconciled, reconsider, regorafenib, regression, relaxing, remitted, remote, renamed, rescinded, resume, RSU, RUL, Russia, SAE, salvage, scan, SCLC, SD, session, shelf, Simon, Sixteen, sotorasib, Susan, SVB, taxation, TEAE, tiered, Toledano, tracing, tract, trigr, TTP, unconfirmed, uninterruptedly, unnecessary, unresectable, unused, upfront, urge, vascular, vascularization, virtue, Vol, waterfall, wholly, York
Filing tables
Filing exhibits
CMPX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement on Form S-8 (File No. 333-252103) of our report, dated March 18, 2022 on our audits of the consolidated financial statements of Compass Therapeutics, Inc. and subsidiaries as of December 31, 2021 and 2020 and for the years then ended, included in this Annual Report on Form 10-K of Compass Therapeutics, Inc. for the year ended December 31, 2021.
/s/ CohnReznick LLP
Melville, New York
March 18, 2022